W
CVS icon

Wealthfront’s CVS Health CVS Stock Holding History

Wealthfront’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$1.63M Buy
20,672
+966
+5% +$69.1K 0.02% 159
2018
Q2 		$1.27M Buy
19,706
+8,123
+70% +$535K 0.01% 203
2018
Q1 		$721K Sell
11,583
-13,232
-53% -$949K 0.01% 320
2017
Q4 		$1.8M Sell
24,815
-96
-0.4% -$6.98K 0.02% 138
2017
Q3 		$2.03M Buy
24,911
+10,832
+77% +$857K 0.03% 108
2017
Q2 		$1.13M Buy
14,079
+2,649
+23% +$209K 0.02% 139
2017
Q1 		$897K Buy
11,430
+858
+8% +$68.5K 0.02% 139
2016
Q4 		$834K Buy
10,572
+133
+1% +$10.8K 0.02% 130
2016
Q3 		$929K Sell
10,439
-5,782
-36% -$546K 0.02% 110
2016
Q2 		$1.55M Sell
16,221
-9,421
-37% -$939K 0.04% 75
2016
Q1 		$2.66M Buy
25,642
+10,656
+71% +$1.04M 0.08% 47
2015
Q4 		$1.47M Buy
14,986
+863
+6% +$84.5K 0.05% 68
2015
Q3 		$1.36M Sell
14,123
-97
-0.7% -$10.2K 0.05% 64
2015
Q2 		$1.49M Buy
14,220
+3,955
+39% +$404K 0.06% 39
2015
Q1 		$1.06M Buy
10,265
+1,158
+13% +$117K 0.05% 40
2014
Q4 		$877K Buy
9,107
+2,087
+30% +$184K 0.05% 41
2014
Q3 		$559K Buy
7,020
+1,999
+40% +$158K 0.04% 53
2014
Q2 		$386K Buy
5,021
+2,128
+74% +$161K 0.03% 52
2014
Q1 		$215K Buy
+2,893
New +$204K 0.03% 50

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Wealthfront's CVS Position: Q3 2018 in Review

Wealthfront increased its CVS Health (CVS) stake by 4.9% in Q3 2018, buying an estimated $69.1K and bringing the position to 20,672 shares worth $1.63M. The position accounts for 0.02% of the portfolio, ranked #159.

Wealthfront first reported a position in CVS in Q1 2014 and has held it in 19 quarters since. The position peaked at $2.66M in Q1 2016. 1,600 funds tracked by Wall St. Rank hold CVS as of Q3 2018.

  • Wealthfront held 20,672 shares of CVS Health worth $1.63M as of Q3 2018.
  • Wealthfront bought 966 CVS Health shares in Q3 2018, an estimated $69.1K.
  • CVS Health made up 0.02% of Wealthfront's portfolio in Q3 2018, its #159 holding.
  • Wealthfront first reported a position in CVS Health in Q1 2014 and has held it in 19 quarters since.
  • Wealthfront's CVS Health position peaked at $2.66M in Q1 2016.
  • 1,600 funds tracked by Wall St. Rank held CVS Health as of Q3 2018.

Based on Wealthfront's 13F filing for Q3 2018, filed 13 Nov 2018.